Image source: The Motley Fool. Illumina Inc ( NASDAQ:ILMN ) Apr 27, 2021 , 5:00 p.m. ET Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: Operator Good day, ladies and gentlemen, and welcome to the Illumina First Quarter 2021 Earnings Conference Call. [Operator Instructions] I would now like to introduce your host for today's conference call, Ms. Juliet Cunningham, VP, Illumina, Investor Relations. Please go ahead, Ms. Cunningham. Juliet Cunningham -- Vice President, Investor Relations Good afternoon, everyone, and welcome to our earnings call for the first quarter of 2021. During the call today, we will review the financial results released after the close of the market and offer commentary on our commercial activity, after which we'll host a question-and-answer session. If you've not had a chance to review the earnings release, it can be found in the Investor Relations section of our website at … [Read more...] about Illumina Inc (ILMN) Q1 2021 Earnings Call Transcript
Pitfalls of whole genome sequencing
Active investing means different things for different people. Some watch their portfolios like hawks, reading conference calls and dissecting financial statements. Others simply buy and hold shares in companies they believe are well managed and forget about them. Whichever path they took, shareholders of Illumina ( NASDAQ:ILMN ) have been handsomely rewarded over the long term. The company has delivered 10-year and 20-year returns of 720% and 8,390%, respectively. But that past success is no guarantee for the future. Here are three things that investors should know about the company right now. Image source: Getty Images. 1. It has a dominant market position The Federal Trade Commission has said Illumina controls roughly 90% of the market for sequencing machines in the U.S. Management estimates that it compiles 80% of the world's genomic information each year. Some have likened the company to Alphabet 's Google because of its dominant market share and its … [Read more...] about 3 Things About Illumina That Smart Investors Know
The tech-heavy Nasdaq Composite has fallen by 5.5% in the last month. Investors are now expecting a faster U.S. economic recovery than they did previously, thanks to the passage of the American Rescue Act stimulus package and the rapid rollout of coronavirus vaccines. Naturally, in this environment, they have been more inclined to shift their investments toward cyclical stocks, rather than the growth and tech stocks that they favored when the situation looked bleaker. But the recent tech sell-off has also created opportunities for savvy investors to buy fundamentally strong high-growth stocks at reasonable prices. If you have $5,000 that you don't expect to need anytime soon, then you might want to think about investing that cash in internet infrastructure company Cloudflare ( NYSE:NET ) and genome sequencing specialist Pacific Biosciences of California ( NASDAQ:PACB ) . Image Source: Getty Images The case for Cloudflare Cloudflare's content delivery … [Read more...] about Have $5,000? Buying These 2 Stocks Could Be Your Best Investing Decision of 2021
Ten years doesn't sound like a long time. In the world of investing, it can seem like eons. Some reports show investors hold the average stock just 5-1/2 months. For a trader focusing on the stock price, that's a lot of red or green days that aren't very meaningful to the business. For an investor focusing on the business, it might only be long enough to hear one quarterly update from management. To keep from getting whiplash, investors in Twist Bioscience ( NASDAQ:TWST ) and Pacific Biosciences of California ( NASDAQ:PACB ) will need to be focused on the long-term opportunity for synthetic DNA and long-read genome sequencing, respectively. Each company has a unique position in the life science industry, but short-term volatility could shake the confidence of anyone worried about the stock price over the next year or two. That's why anyone adding these stocks to a portfolio should plan to own them for a decade or more. Image source: Getty Images. 1. Twist … [Read more...] about 2 Top Biotech Picks to Buy and Hold for the Next 10 Years
In the world of genome sequencing, Illumina ( NASDAQ:ILMN ) is the undisputed market leader. Pacific Biosciences of California ( NASDAQ:PACB ) , or PacBio, has been viewed as more of an also-ran since it went public in 2010. Its "long-read" gene sequencing technology was traditionally less accurate than Illumina's competing "short-read" approach, and it comes at a higher cost. However, after new leadership was brought on and a product update was delivered, its shares have jumped by 700% since the beginning of August. Is the company finally ready to compete in the growing $5 billion gene sequencing market, or will this hot stock blow up shareholders' portfolios when reality sets in? Image source: Getty Images A new beginning If it weren't for the Federal Trade Commission (FTC), PacBio would already be part of Illumina. Plans for a $1.2 billion merger that was first announced in November 2018 fell apart in January 2020 after the agency objected on … [Read more...] about Is Pacific Biosciences of California a Ticking Time Bomb for Investors?